

%201.webp)


%201.webp)




LSPedia Global Serialization Series
序列化并非一刀切。美国、欧盟、亚洲和中东的法规要求各不相同,企业必须应对错综复杂的要求。您准备好实现全球合规了吗?
.avif)
欢迎来到 LSPedia,在这里,创新与奉献相遇。
如果您热衷于有所作为,并能在协作环境中茁壮成长,LSPedia 就是您的理想之选。



%201.webp)


%201.webp)




序列化并非一刀切。美国、欧盟、亚洲和中东的法规要求各不相同,企业必须应对错综复杂的要求。您准备好实现全球合规了吗?
.avif)
如果您热衷于有所作为,并能在协作环境中茁壮成长,LSPedia 就是您的理想之选。


On August 6, 2026, the FDA extended its DSCSA exemption for small dispensers, pushing the deadline from November 27, 2026 to November 27, 2027 (1). A small dispenser is a pharmacy whose owning company has 25 or fewer full-time employees licensed as pharmacists or qualified as pharmacy technicians, counted as of November 27, 2026. The extra time lets FDA finish its required assessment of small dispensers’ package-level tracing capabilities, including a survey it asked small dispensers to complete by September 22, 2026, a public comment period on the final report and a public meeting on the findings (1).
If you're a small pharmacy, that headline probably landed as good news. And it is — but not in the way a lot of people are about to assume.
The exemption covers only certain enhanced drug distribution security requirements: exchanging transaction information electronically and interoperably, including package-level product identifiers, the related electronic verification and response systems, and product identifier checks on a set share of suspect product (1). Everything else in Section 582 still applies.
Here's the trap: "exemption" sounds like "off the hook." It isn't. The FDA has been explicit, in this announcement and the ones before it, that the relief is narrow. It applies to specific enhanced drug distribution security (EDDS) requirements — mainly the obligation to exchange transaction data electronically, at the package level, using interoperable systems (EPCIS). It is not a blanket exemption from Section 582 of the FD&C Act, and it is not a delay of DSCSA itself.
That distinction matters because a meaningful list of DSCSA duties were never part of the exemption to begin with. They've applied all along, exemption or not — and they're exactly the kind of thing an auditor or regulator will ask about.
Small dispensers must still buy only from Authorized Trading Partners, keep transaction information and statements for six years, quarantine and investigate suspect product, notify FDA and trading partners within 24 hours of finding illegitimate product, and answer regulator requests for tracing information within 2 business days (2). Manual methods are fine for now. Here’s the full list:
None of this requires the electronic, interoperable EPCIS infrastructure that big distributors and manufacturers have had to build. But it does require having answers ready — in writing, on demand — for every item above.
No. The extension only delays electronic, interoperable tracing, and FDA says it should not be viewed as a reason to delay implementation (1). The rest of a small pharmacy’s DSCSA duties apply today, and a regulator’s request for tracing information comes with a 2-business-day deadline whether or not the pharmacy is exempt.
The FDA’s own framing of the extension is telling: it’s giving itself time to run an assessment, publish findings, and hold a public meeting. The letter also says the exemption is no reason to delay, and it strongly urges small dispensers to keep implementing the enhanced requirements (1).
The 2-business-day response window is the one that tends to catch people off guard. If a state board or FDA investigator asks for tracing records and your SOPs, quarantine logs, and ATP verification aren’t already organized, two business days is not enough time to build them from scratch.
We built OneScan Pharmacy Pro’s compliance modules around this exact list, because it’s the list that determines what actually gets checked.
The 2027 extension buys small dispensers real time on the hardest, most expensive part of DSCSA compliance: full electronic interoperability. It doesn't touch the rest. If your pharmacy is treating this extension as a reason to wait, the gap between “exempt” and “compliant” is exactly where an audit will find you.
OneScan Pharmacy Pro brings Authorized Trading Partner checks, six-year record retention, suspect product workflows and Form 3911 reporting into one system for independent and small pharmacies. See how Pharmacy Pro works or browse our resources for dispensers.